XTNT Xtant Medical Holdings

Xtant Medical to Participate in Upcoming Investor Conferences

Xtant Medical to Participate in Upcoming Investor Conferences

BELGRADE, Mont., Feb. 05, 2024 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that management will participate in two upcoming investor conferences:

Canaccord Genuity 2024 Musculoskeletal Conference – February 12

  • Sean Browne, President and CEO, will present on Monday, February 12 at 9:00 AM PT / 12:00 PM ET and participate in 1x1 meetings with institutional investors in San Francisco.

A live webcast of the Canaccord presentation will be available on the Investors section of the Company’s website at . A replay of the webcast will be available following the conclusion of the presentation.

BTIG Medtech, Digital Health, Life Science and Diagnostic Tools Conference – February 13 - 14

  • Mr. Browne and Scott Neils, Chief Financial Officer, will participate in 1x1 meetings with institutional investors in Snowbird, UT.

About Xtant Medical Holdings, Inc.

Xtant Medical’s mission of honoring the gift of donation so that our patients can live as full and complete a life as possible, is the driving force behind our company. Xtant Medical Holdings, Inc. () is a global medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Xtant people are dedicated and talented, operating with the highest integrity to serve our customers.

The symbols™ and ® denote trademarks and registered trademarks of Xtant Medical Holdings, Inc. or its affiliates, registered as indicated in the United States, and in other countries. All other trademarks and trade names referred to in this release are the property of their respective owners.

Investor Relations Contact

David Carey

Lazar FINN

Ph: 212-867-1762

Email:



EN
05/02/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Xtant Medical Holdings

 PRESS RELEASE

Xtant Medical Announces Launch of SimpliGraft™ and SimpliMax™ for Chro...

Xtant Medical Announces Launch of SimpliGraft™ and SimpliMax™ for Chronic and Acute Wounds BELGRADE, Mont., April 30, 2024 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the full commercial launch of two amniotic membrane allografts, SimpliGraft™ and SimpliMax™. “The launches of SimpliGraft and SimpliMax highlights the strength of our newly revitalized Research and Development team,” said Sean Browne, President and CEO of Xtant Medical. “...

 PRESS RELEASE

Xtant Medical Announces Record Full Year 2023 Revenue of $91.3 Million

Xtant Medical Announces Record Full Year 2023 Revenue of $91.3 Million Establishes Full Year 2024 Revenue Guidance of $112 Million - $116 Million BELGRADE, Mont., April 01, 2024 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today reported financial and operating results for the fourth quarter and year ended December 31, 2023. “2023 was a transformative year for Xtant Medical. We achieved record annual revenues of $91.3 million, up 58% year-over-year, on whic...

 PRESS RELEASE

Xtant Medical to Issue Fourth Quarter and Full Year 2023 Financial Res...

Xtant Medical to Issue Fourth Quarter and Full Year 2023 Financial Results on April 1, 2024 BELGRADE, Mont., March 21, 2024 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financial results for the fourth quarter and full year ended December 31, 2023, before the open of the financial markets on Monday, April 1, 2024. Sean Browne, President and Chief Executive Officer, and Scott Neils, Chief Financial Officer, will host a...

 PRESS RELEASE

Xtant Medical Increases Revolving Credit Facility to $17 Million with ...

Xtant Medical Increases Revolving Credit Facility to $17 Million with MidCap Financial BELGRADE, Mont., March 07, 2024 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that the Company’s revolving credit agreement with MidCap Financial Trust (“MidCap”) was amended to increase the commitment from $8.0 million to $17.0 million. The Company’s term loan was also amended to provide for an additional $10.0 million tranche, to be made available for acqui...

 PRESS RELEASE

Xtant Medical to Present at the TD Cowen 44th Annual Healthcare Confer...

Xtant Medical to Present at the TD Cowen 44th Annual Healthcare Conference BELGRADE, Mont., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that Sean Browne, Chief Executive Officer, will present at the TD Cowen 44th Annual Healthcare Conference, to be held on Monday, March 4, 2024 at 12:50 p.m. Eastern Time in Boston. A live webcast of the presentation will be available on the Investors section of the Company’s website or through ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch